Reproducibility of radioactive iodine uptake (RAIU) measurements
- PMID: 29165912
- PMCID: PMC5768031
- DOI: 10.1002/acm2.12217
Reproducibility of radioactive iodine uptake (RAIU) measurements
Abstract
Background: Measurement of radioactive iodine uptake (RAIU) is an important aspect of the assessment and treatment of patients with hyperthyroidism. Its uncertainty affects how much of a true change in RAIU can be detected as well as appropriateness of the therapy dosage upon which it is based. In this study, a method of estimating the reproducibility and least significant change (LSC) values for RAIU measurements, and the implications of the values observed are discussed, with emphasis on application to quality assurance initiatives.
Methods: We prospectively studied 36 consecutive patients referred for RAIU measurements. Twenty-four hours after oral administration of 370 kBq of 131 I-NaI in capsule form, RAIU measurements were obtained in duplicate using a thyroid probe uptake system. Assessment of reproducibility was performed using root-mean-square standard deviation.
Results: Average difference between duplicated RAIU measurements in our study cohort was -0.1 ± 1.6% and ranged from -4.8% to 3.1%. Reproducibility of probe-based RAIU measurement was calculated to be 1.1% and 95% LSC was 3.2%.
Conclusion: In our clinic, probe-based RAIU is a reproducible and relatively precise measurement. Using the method we have outlined, each institution can perform reproducibility assessment and compute the LSC of RAIU measurements based on its own staff, iodine isotope, equipment, protocols, and patient population. These values are useful in the assessment of serial change in RAIU, and as more experience is accumulated, can serve as benchmarks to be used in quality assurance initiatives.
Keywords: hyperthyroidism; radioiodine therapy; radioiodine thyroid uptake; reproducibility.
© 2017 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.
Figures


Similar articles
-
Least Significant Changes and Reproducibility of 131I Uptake Test.Health Phys. 2021 Mar 1;120(3):316-320. doi: 10.1097/HP.0000000000001325. Health Phys. 2021. PMID: 33044424
-
Assessment of Minimum 124I Activity Required in Uptake Measurements Before Radioiodine Therapy for Benign Thyroid Diseases.J Nucl Med. 2016 Aug;57(8):1201-6. doi: 10.2967/jnumed.115.171066. Epub 2016 Mar 16. J Nucl Med. 2016. PMID: 26985060 Clinical Trial.
-
Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.Thyroid. 2011 Jul;21(7):759-64. doi: 10.1089/thy.2010.0088. Epub 2011 May 13. Thyroid. 2011. PMID: 21568727
-
Initial radioiodine administration: when to use it and how to select the dose.Endocrinol Metab Clin North Am. 2014 Jun;43(2):385-400. doi: 10.1016/j.ecl.2014.02.003. Endocrinol Metab Clin North Am. 2014. PMID: 24891168 Review.
-
Radioiodine therapy and thyrostatic drugs and iodine.Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S486-91. doi: 10.1007/s00259-002-0868-4. Epub 2002 Jun 27. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192550 Review.
Cited by
-
Normal reference values for Tc-99m pertechnetate thyroid uptake in northern Iranian population: A single-center experience.Caspian J Intern Med. 2024 Summer;15(3):459-465. doi: 10.22088/cjim.15.3.459. Caspian J Intern Med. 2024. PMID: 39011436 Free PMC article.
-
Gamma camera-specific reference standards for radioactive iodine uptake measurements.EJNMMI Phys. 2023 Sep 13;10(1):55. doi: 10.1186/s40658-023-00575-2. EJNMMI Phys. 2023. PMID: 37702889 Free PMC article.
References
-
- Chapman EM, Maloof F. The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism: ten years’ experience. Med (Baltimore). 1955;34:261–322. - PubMed
-
- Werner SC, Hamilton HB, Leifer E, et al. An appraisal of the radioiodine tracer technic as a clinical procedure in the diagnosis of the thyroid disorders; uptake measurement directly over the gland and a note on the use of thyrotropin (T.S.H.). J Clin Endocrinol Metab. 1950;10:1054–1076. - PubMed
-
- Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17:456–520. - PubMed
-
- Chapman EM. History of the discovery and early use of radioactive iodine. JAMA. 1983;250:2042–2044. - PubMed
-
- Hamburger JI. Subacute thyroiditis: diagnostic difficulties and simple treatment. J Nucl Med. 1974;15:81–89. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical